- Home
- ENOV
ENOV
Enovis Corporation
as 01-17-2025 4:00pm EST
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 2.4B | IPO Year: | 2008 |
| Target Price: | $67.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.27 - $65.03 | Next Earning Date: | 02-20-2025 |
| Revenue: | $2,001,668,000 | Revenue Growth: | 20.52% |
| Revenue Growth (this year): | 25.59% | Revenue Growth (next year): | 5.74% |
Latest Enovis Corporation News
ENOV Breaking Stock News: Dive into ENOV Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Enovis™ Announces Leadership Change to International Surgical Business
Zacks
3 days ago
Centene Expands Care in Hawaii With a Residential Program
Argus Research
4 days ago
ENOV: What does Argus have to say about ENOV?
Investopedia
10 days ago
Instacart Is Joining the S&P MidCap 400. Its Stock Is Rising.
MT Newswires
11 days ago
Maplebear to Replace Enovis in S&P MidCap 400 Index
PR Newswire
11 days ago
Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600
Zacks
11 days ago
Here's Why Investors Should Retain Molina Healthcare Stock for Now
GlobeNewswire
12 days ago
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Compare ENOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.